期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

抗血小板药抵抗现象及临床策略

下载PDF
导出
摘要 通过阐述抗血小板药物抵抗的概念、发生的原因、影响因素、检测方法的稳定性和困难性以及与临床卒中疾病发病的相互矛盾，提出抗血小板药物抵抗的重要临床意义不仅为能否较好控制血栓形成一个方面，同时还在于对慢性炎症的调控以及对动脉粥样硬化的发生发展的影响。建议抗血小板药物抵抗的高危患者，应给予积极的个体化治疗。
作者 刘远波(综述 周伯荣(审校)
机构地区 广州医科大学附属第三医院神经内科
出处 《中风与神经疾病杂志》 CAS CSCD 北大核心 2013年第11期1045-1047,共3页 Journal of Apoplexy and Nervous Diseases
关键词 抗血小板药 临床意义 抵抗现象 药物抵抗 动脉粥样硬化 个体化治疗 血栓形成 慢性炎症
分类号 R97 [医药卫生—药品]
  • 相关文献

参考文献29

  • 1Gorog DA, SweenyJM, Fuster V. Antiplatelet drug resistance. Part 2: laboratory resistance to antiplatelet drugs-fact or artifact[J]. Nat Rev Cardiol,2009,6:365 -373.
  • 2Howard PA. Aspirin resistance[J]. Ann Pharmaeother, 2002, 36 (100) : 1620 -1624.
  • 3Gum P A , Kottke- Marthant K, Poggio ED, el al. Profile and prevalence of aspirin resistance in patients with cardiovascular disease[J]. AmJ Cardiol,2001 ,88(3) :230 -235.
  • 4Gurbel PA, Bliden KP , Hiatt BL, et al. Clopidogrel for coronary stent?ing response variability, drugresistance , and the effect of pretreatment platelet reactivity[J]. Circulation, 2003 , 107 : 2908 - 2913.
  • 5Muller I, Besta F, Schulz C, et al. Prevalenceof clopidogrel nonre?sponers among patients with stable angina pectoffs scheduled for elec?tive coronary stent placement[J]. Thromb Hae most ,2003 ,89: 783 - 787.
  • 6Barragan P , BouvierJL, Roquebert PO, et al. Resistance to thienopyri dines: clini -phosphoprotein phosphory lation[J]. Catheter Cardiovasc Interv ,2003 ,59 (3) :295 - 302.
  • 7Pamukcu B, Oflaz H, Onur I, et al. Aspirin resistant platelet aggqega?tion in a cohort of patients with coronary heartdisease[J]. Blood Cuagul Fibrinolysis,2007 ,18(5) :461 -465.
  • 8SnoepJD, Hovens MM, EikenbocmJC, et al. Clopidogrel nonrespons?iveness in patients undergoing pereutaneous coronary intervention with stenting , a systematic review and meta-analysis[J]. Am HeartJ, 2007,154 :221 - 231.
  • 9Sibbing D, Braun S, Morath T, et al. Platelet reactivity after clopi?dogreltreatment assessed with point-of-care analysis and early drug e?luting stent thrombosis[J].J Am Coil Cardiol,2009,53:849 -856.
  • 10Gurbel PA, Bliden KP, DiChiaraJ. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect ( ASPECT) study[J]. Circulation, 2007 , 115 (25) : 3156 -3164.

二级参考文献13

  • 1Chen ZM, Jiang LX, Chen YP, et al. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction:randomised placebo-controlled trial[J]. Lancet, 2005, 366:1607-1621.
  • 2Soft F, Marcucci R, Gori AM, et al. Clopidogrel non- responsiveness and risk of cardiovascular morbidity. An updated meta-analysis[J]. Thromb Haemost, 2010, 103:841-848.
  • 3Hart SW, Kim SH, Lee JY, et al. A new subtype classification of ischemic stroke based on treatment and etiologic mechanism[J]. Eur Neurol, 2007, 57:96- 102.
  • 4Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting:response variability, drug resistance, and the effect of pretreatment platelet reactivity[J]. Circulation, 2003, 107:2908-2913.
  • 5Patrono C, Bachmann F, Baigent C, et al. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European society of cardiology[J]. Eur Heart J, 2004, 25:166-181.
  • 6Gurbel PA, Becker RC, Mann KG, et al. Platelet function monitoring in patients with coronary artery disease[J]. J Am Coll Cardiol, 2007, 50:1822-1834.
  • 7Lee JM, Park S, Shin DJ, et al. Relation of genetic polymorphisms in the cytochrome P450 gene with clopidogrel resistance after drug-eluting stent implantation in koreans[J]. Am J Cardiol, 2009, 104:46-51.
  • 8Collet JP, Montalescot G. Platelet function testing and implications for clinical practice[J]. J Cardiovasc Pharmacol Ther, 2009, 14:157-169.
  • 9Westerbacka J, Yki HJ, Turpeinen A, et al. Inhibition of platelet-collagen interaction:an in vivo action of insulin abolished by insulin resistance in obesity[J]. Arterioscler Thromb Vasc Biol, 2002, 22:167-172.
  • 10Lepantalo A, Virtanen KS, Heikkila A J, et al. Limited early antiplatelet effect of 300 mg clopidogrel in patients with aspirin therapy undergoing percutaneous coronary interventions[J]. Eur Heart J, 2004, 25:476- 483.

共引文献10

中风与神经疾病杂志
2013年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部